Editorials and Opinions

In medicine, spending more is not always better.

A Look at ICER’s Unsupported Drug Price Increase Report

A Look at the Trump Administration’s Pharmaceutical Pricing Policy Proposals

Today, three companies control virtually the entire global market for insulin.

America's secret drug pricing system.

More than half of new drugs entering the German healthcare system have failed to demonstrate any added benefit.

Predictions and Solutions for a Global Obesity Epidemic

A new low for the pharmaceutical industry's image.

While new formulations of drugs can provide benefits to patients, in some cases new formulations are introduced toward the end of a drug's patent or exclusivity, a practice often referred to as "product hopping".

Americans support government action to curb prescription drug prices

Practices that undermine biopharmaceutical innovation.

Who are the largest investors in U.S. medical and health R&D?

Brand name drug price hikes are an industry-wide phenomenon.

What do cancer drugs improve?

The law reforming the pharmaceutical market in Germany (ArzneimittelmarktNeuordnungsgesetz – AMNOG) took effect in January 2011.